United States · Bill · S
S. 3021 (116th)
Gluten in Medicine Disclosure Act of 2019
Introduced
11 December 2019
Last action
11 December 2019 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Richard Blumenthal
Subjects
Healthcare
Source updated
5 December 2025
Summary
Gluten in Medicine Disclosure Act of 2019 This bill prohibits the sale of any drug intended for human use that contains an ingredient derived from a gluten-containing grain unless the drug's label (1) states that the drug contains such an ingredient, and (2) identifies the type of grain from which the ingredient is derived.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 December 2019
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
11 December 2019
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 11 December 2019 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 11 December 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 11 December 2019
Introduced in Senate
summary · EN · 11 December 2019
Sponsors
- Richard Blumenthal · D · Sponsor
- · sshr00 · Standing
Related records
- related to → Gluten in Medicine Disclosure Act of 2019
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/3021
- Open data entity: https://api.congress.gov/v3/bill/116/s/3021
- us · 116-s-3021 · source updated 5 December 2025